Location History:
- Duarte, CA (US) (2016)
- Athens, GR (2005 - 2021)
Company Filing History:
2 out of 639 
1 out of 4 
1 out of 7 Years Active: 2005-2021
Title: The Innovator Alexios-Leandros Skaltsounis: Pioneering Advances in Therapeutics
Introduction
Alexios-Leandros Skaltsounis, an accomplished inventor based in Athens, Greece, has made significant strides in the field of pharmaceuticals and therapeutics. With a total of three patents to his name, his contributions have been instrumental in the development of novel treatments for chronic conditions, particularly in oncology.
Latest Patents
Skaltsounis's latest inventions include groundbreaking patents for pyridopyrazine compounds and their applications. These compounds include innovative methods for their utilization in medical treatment. Additionally, he has developed indirubin derivatives aimed at treating chronic myelogenous leukemia (CML). The major active component of a traditional Chinese herbal medicine, indirubin has been shown to be effective against CML by inhibiting vital signaling pathways in cancer cells. His research into compound IRD 810, particularly its ability to obstruct the Bcr-Abl/Stat5 and Src/Stat5 signaling pathways, presents exciting new therapeutic options for patients with both wild type and T315I mutant Bcr-Abl-positive CML, and may also extend to other solid tumors, including prostate cancer and lymphoma.
Career Highlights
Throughout his career, Skaltsounis has been associated with prominent research institutions, including City of Hope, where he delved into cutting-edge cancer research, and Lavipharm S.A., contributing to the pharmaceutical industry's advancements. His work has not only garnered patents but has also been pivotal in fostering innovation in cancer therapies.
Collaborations
Alexios-Leandros Skaltsounis has collaborated with renowned professionals in his field, such as Sangkil Nam and Spiros A. Fotinos. These partnerships have enriched his research endeavors and have facilitated the creation of novel pharmaceutical compounds aimed at improving patient outcomes in cancer treatment.
Conclusion
In summary, Alexios-Leandros Skaltsounis stands out as a significant inventor in the pharmaceutical sector, with a focus on developing innovative treatments for complex diseases like chronic myelogenous leukemia. His latest patents not only illustrate his expertise and creativity but also reflect a commitment to improving therapeutic options for patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.